Proceedings of the Ninth International Conference of Drug Regulatory Authorities (ICDRA) - Berlin, Germany 25-29 April 1999
(1999; 102 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuOpening Ceremony
Ouvrir ce répertoire et afficher son contenuGood regulatory practice
Ouvrir ce répertoire et afficher son contenuGood certification practice
Ouvrir ce répertoire et afficher son contenuCounterfeit drugs: challenges and solutions
Ouvrir ce répertoire et afficher son contenuCurrent issues in regulation and quality
Ouvrir ce répertoire et afficher son contenuInternational Conference on Harmonization: implementation and implications
Ouvrir ce répertoire et afficher son contenuDrug utilization studies
Ouvrir ce répertoire et afficher son contenuInternational Conference on Harmonization and the common technical document
Ouvrir ce répertoire et afficher son contenuKeynote address
Ouvrir ce répertoire et afficher son contenuGlobal and national efforts to reduce tobacco use
Ouvrir ce répertoire et afficher son contenuElectronic communication in the regulatory process
Ouvrir ce répertoire et afficher son contenuTransparency in monitoring the safety of medicines
Ouvrir ce répertoire et afficher son contenuPharmaceutical products for use in special groups
Ouvrir ce répertoire et afficher son contenuNeed for Bioequivalence
Ouvrir ce répertoire et afficher son contenuAntimicrobial resistance: battling the bugs
Ouvrir ce répertoire et afficher son contenuSafety issues of plasma-derived medicinal products
Ouvrir ce répertoire et afficher son contenuHerbal medicines
Fermer ce répertoireRegulation and access to essential drugs
Afficher le documentPricing policy and regulation
Afficher le documentRegulation and community drug programmes
Afficher le documentAvailability of essential drugs during an economic crisis
Afficher le documentClassification of drugs
Afficher le documentThe role of the drug regulatory authority in drug donation
Afficher le documentThe role of the regulatory authority in improving access to drugs
Afficher le documentRecommendations
Afficher le documentParticipants
Afficher le documentBack cover
 

The role of the drug regulatory authority in drug donation

Dr G. Erdenetsetseg, Mongolia

As a result of democratic reforms in Mongolia, the social and economic situation has changed rapidly. Among the difficulties encountered as a result of these changes is drug access and availability, while budget shortages, low purchasing power among the population, a small market, and other factors aggravate the situation.

Mongolia imports about 85% of its pharmaceutical products. A centralized public agency for drug supply is responsible for approximately 75-80% of drug procurement. For the most part, private enterprises conduct drug retailing functions.

Since 1992, Mongolia has received donations of drugs in the amount of more than US$6 million. These donations were received as a result of Government requests from donor countries, with the support of UN agencies. Other kinds of drug donations to Mongolia have been received. These have been made through agreements between hospitals, as direct donations to specific population groups, and in the form of emergency assistance.

From the sale of donated drugs, the Government has created the Drug Revolving Fund for financing drug supplies. The donation of drugs has played a crucial role in the implementation of a national drug policy, and in providing drug supplies during transitional years. Drug donations are extremely important in times of economic difficulty. Proper management of drug donations can realize the greatest benefit for the health of the population.

The recipient country should have its own drug policy, good working drug procurement, and an effective distribution system. Competent information exchange concerning drug donations has been crucial. However, because of limited information, some %unnecessary donations have been received. Due to lack of drug donation regulations, Mongolia has had to return or to discard some portions of donated drug supplies.

As a recipient of drug donations for the last seven years, the experience of Mongolia has demonstrated the importance of legislative and administrative regulations for drug donations. These regulations are necessary to avoid donors incurring unnecessary expense, and to achieve the highest possible benefit for the population of the recipient country.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013